WHWK

WHITEHAWK THERAPEUTICS INC

WHWK·00032Q104·US·Common Stock·Healthcare - Biotechnology-Activist

WHWK (WHITEHAWK THERAPEUTICS INC) is held by 37 institutional investors as of Q1 2026. Largest holders: Avoro Capital Advisors LLC ($9.8M), VANGUARD CAPITAL MANAGEMENT LLC ($4.5M), BALYASNY ASSET MANAGEMENT L.P. ($1.9M). Net institutional sentiment: Bullish.

37
Holders
Avg rating(5 Elite)
$28M
Total Value
74% (40)
Fund Consensus
26 buying - 9 selling
WHWKSmart Money Verdict
View all
Held by 37 funds
5 elite
Who's Trading
ActivistACACUTA CAPITAL PARTNERS, LLC8.7%May 18, 2026
ActivistAvoro Capital Advisors LLCAvoro Capital Advisors LLC20.0%May 14, 2026
InsiderGMGiacobello Scott M.Sell $585KApr 16, 2026
InsiderGMGiacobello Scott M.Sell $297KApr 15, 2026
InsiderBBBALL BRYANSell $337KApr 14, 2026
InsiderBBBALL BRYANSell $91KApr 13, 2026
InsiderBBBALL BRYANSell $23KApr 10, 2026
InsiderBBBALL BRYANSell $179KApr 9, 2026
InsiderLJLennon David JamesSell $49KApr 9, 2026
InsiderLJLennon David JamesSell $217KApr 8, 2026
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Unchanged
2.8M$9.8M0.1%-83.40%
0
New
1.3M$4.5M0.0%+20.30%
37
New
550,441$1.9M0.0%+20.30%
36
Increased
457,540(+7.5%)$1.6M0.0%-51.49%
28
Decreased
428,622(-2.8%)$1.5M0.0%-51.01%
0
Increased
351,385(+17.5%)$1.2M0.0%+39.76%
20
New
309,674$1.1M0.0%+20.30%
35
New
281,497$971,1650.0%+20.30%
35
Decreased
273,482(-11.7%)$943,5130.0%+60.73%
0
New
214,827$741,1530.0%+20.30%
34
Increased
203,465(+84.8%)$701,9540.0%+39.25%
38
Increased
160,382(+10.2%)$553,3180.0%+67.09%
18
Increased
151,110(+116.1%)$521,3300.0%+40.54%
39
Increased
107,266(+3.7%)$370,0670.0%-47.25%
17
Decreased
91,852(-7.2%)$316,8890.0%+80.81%
0
New
57,597$198,7100.0%+20.30%
32
New
56,912$196,3460.0%+20.30%
35
Increased
52,861(+128x)$182,3700.0%+20.54%
25
Decreased
48,307(-33.2%)$166,6590.0%+60.73%
0
Increased
30,090(+5.1%)$103,8100.0%+9.90%
16

Showing 1-20 of 40

1 / 2

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used